Ketamine Completed Phase 3 Trials for Pain Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01326325Efficacy of Low Analgesic Doses of Ketamine Associated With Opioids in Refractory Cancer Pain Treatment
NCT01022840The Preemptive Analgetic Potency of Low Dose S-Ketamine
NCT00484484Ketamine Associated With Opioids in Refractory Cancer Pain Treatment